Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions
Abstract INTRODUCTION Benznidazole (BNZ) is a drug available for the etiological treatment of Chagas disease. However, this drug is toxic and has a limited effectiveness on the chronic phase of this disease, often leading to poor treatment adherence. METHODS: This is a descriptive and explorator...
Main Authors: | João Paulo Ramalho Correia, Alanna Carla da Costa, Eduardo Arrais Rocha, Ana Rosa Pinto Quidute, Darlan da Silva Cândido, Ângela Maria de Souza Ponciano, Marta Maria de França Fonteles, Maria de Fátima Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017002300334&lng=en&tlng=en |
Similar Items
-
Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study
by: Monica Coelho Andrade, et al.
Published: (2013-12-01) -
Satisfação dos pacientes com doença de Chagas atendidos por um serviço de atenção farmacêutica no estado do Ceará, Brasil
by: Alanna Carla da Costa, et al. -
Implementation of aid as pharmaceutical innovation towards national and foreign pharmaceutical practice
by: L. M. Unhurian, et al.
Published: (2017-02-01) -
Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report
by: Valeria Rita Corrêa, et al.
Published: (2014-06-01) -
Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
by: Maria Jose Morilla, et al.
Published: (2005-04-01)